Conestoga Capital Advisors Increased West Pharmaceutical Svsc (WST) Position By $1.36 Million; Point72 Asset Management LP Has Raised By $4.80 Million Its Cal Maine Foods (CALM) Holding

January 14, 2018 - By Linda Rogers

Conestoga Capital Advisors Llc increased West Pharmaceutical Svsc Inc (WST) stake by 120.75% reported in 2017Q3 SEC filing. Conestoga Capital Advisors Llc acquired 14,218 shares as West Pharmaceutical Svsc Inc (WST)’s stock rose 14.65%. The Conestoga Capital Advisors Llc holds 25,993 shares with $2.50M value, up from 11,775 last quarter. West Pharmaceutical Svsc Inc now has $7.26 billion valuation. The stock decreased 1.36% or $1.35 during the last trading session, reaching $97.74. About 414,340 shares traded or 16.48% up from the average. West Pharmaceutical Services, Inc. (NYSE:WST) has risen 33.75% since January 14, 2017 and is uptrending. It has outperformed by 17.05% the S&P500.

Point72 Asset Management Lp increased Cal Maine Foods Inc (CALM) stake by 481.89% reported in 2017Q3 SEC filing. Point72 Asset Management Lp acquired 117,100 shares as Cal Maine Foods Inc (CALM)’s stock rose 0.65%. The Point72 Asset Management Lp holds 141,400 shares with $5.81 million value, up from 24,300 last quarter. Cal Maine Foods Inc now has $2.15 billion valuation. The stock decreased 2.75% or $1.25 during the last trading session, reaching $44.2. About 492,562 shares traded or 48.61% up from the average. Cal-Maine Foods, Inc. (NASDAQ:CALM) has declined 14.94% since January 14, 2017 and is downtrending. It has underperformed by 31.64% the S&P500.

Since December 8, 2017, it had 0 buys, and 1 sale for $2.08 million activity. Another trade for 21,000 shares valued at $2.08 million was made by FEDERICI WILLIAM J on Friday, December 8.

Among 5 analysts covering West Pharmaceutical Services (NYSE:WST), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. West Pharmaceutical Services had 13 analyst reports since August 4, 2015 according to SRatingsIntel. Jefferies maintained the stock with “Hold” rating in Monday, September 11 report. The rating was initiated by Janney Capital on Friday, January 8 with “Buy”. The firm earned “Market Perform” rating on Wednesday, September 21 by Wells Fargo. The firm has “Hold” rating given on Thursday, July 27 by Jefferies. The firm has “Buy” rating by Jefferies given on Friday, September 15. Jefferies maintained West Pharmaceutical Services, Inc. (NYSE:WST) rating on Tuesday, June 6. Jefferies has “Hold” rating and $9000 target. Wells Fargo maintained West Pharmaceutical Services, Inc. (NYSE:WST) rating on Friday, October 27. Wells Fargo has “Outperform” rating and $112 target. Wells Fargo upgraded West Pharmaceutical Services, Inc. (NYSE:WST) on Friday, October 28 to “Outperform” rating. Zacks downgraded the stock to “Hold” rating in Tuesday, August 4 report. The firm earned “Hold” rating on Tuesday, October 17 by Bank of America.

Investors sentiment decreased to 1.33 in 2017 Q3. Its down 0.28, from 1.61 in 2017Q2. It turned negative, as 31 investors sold WST shares while 76 reduced holdings. 42 funds opened positions while 100 raised stakes. 68.09 million shares or 1.49% more from 67.09 million shares in 2017Q2 were reported. Strs Ohio has invested 0.06% of its portfolio in West Pharmaceutical Services, Inc. (NYSE:WST). Stephens Ar, a Arkansas-based fund reported 2,186 shares. Duncker Streett Company, a Missouri-based fund reported 130 shares. Credit Suisse Ag has 0.01% invested in West Pharmaceutical Services, Inc. (NYSE:WST). Minnesota-based Advantus Cap Management has invested 0.02% in West Pharmaceutical Services, Inc. (NYSE:WST). 1832 Asset LP stated it has 0.21% in West Pharmaceutical Services, Inc. (NYSE:WST). Tcw Gru owns 315,268 shares or 0.24% of their US portfolio. Barclays Public Ltd Co holds 0% or 946 shares. Paloma Prtnrs Management reported 0% stake. Finance Counselors reported 9,162 shares. Eaton Vance Mgmt has invested 0.08% in West Pharmaceutical Services, Inc. (NYSE:WST). 1,932 were reported by Burt Wealth Advisors. Goldman Sachs Gru reported 0.02% of its portfolio in West Pharmaceutical Services, Inc. (NYSE:WST). First Quadrant Lp Ca has invested 0.52% in West Pharmaceutical Services, Inc. (NYSE:WST). Maryland-based Price T Rowe Md has invested 0.15% in West Pharmaceutical Services, Inc. (NYSE:WST).

Conestoga Capital Advisors Llc decreased Tyler Technologies Inc (NYSE:TYL) stake by 61,268 shares to 157,945 valued at $27.53M in 2017Q3. It also reduced Align Technology Inc (NASDAQ:ALGN) stake by 191,712 shares and now owns 16,339 shares. Costar Group Inc (NASDAQ:CSGP) was reduced too.

Point72 Asset Management Lp decreased Cooper Tire & Rubr Co (NYSE:CTB) stake by 184,400 shares to 29,100 valued at $1.09M in 2017Q3. It also reduced Genesee & Wyo Inc (NYSE:GWR) stake by 13,123 shares and now owns 13,200 shares. Middleby Corp (NASDAQ:MIDD) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>